Treatment of underlying atrial fibrillation: paced rhythm obscures recognition.
暂无分享,去创建一个
H. Frumin | A. M. Patel | J. Stewart | D. Westveer | A M Patel | J R Stewart | D C Westveer | K C Man | H I Frumin | K. Man
[1] H. Katayama,et al. Contrast sonography for detection of vesicoureteral reflux , 1994, The Lancet.
[2] W. Grimm,et al. Atrial Fibrillation and Embolic Complications in Paced Patients , 1988, Pacing and clinical electrophysiology : PACE.
[3] J. Avorn,et al. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting. , 1997, Archives of internal medicine.
[4] V. Fuster,et al. Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. , 1996, Circulation.
[5] Leandro Provinciali,et al. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .
[6] J. Gardin,et al. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). , 1994, The American journal of cardiology.
[7] H. Mond,et al. Atrial Fibrillation and Anticoagulation in Patients with Permanent Pacemakers: Implications for Stroke Prevention , 1998, Pacing and clinical electrophysiology : PACE.
[8] Lippincott Williams Wilkins,et al. Stroke Prevention in Atrial Fibrillation Study: Final Results , 1991, Circulation.
[9] Eaft Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993, The Lancet.
[10] H. White,et al. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation : stroke prevention in atrial fibrillation II study. Commentary , 1994 .
[11] J. Whittle,et al. Is warfarin underused in the treatment of elderly persons with atrial fibrillation? , 1997, Archives of internal medicine.
[12] W. J. Hamilton,et al. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial , 1996, The Lancet.
[13] H. Krumholz,et al. Warfarin use following ischemic stroke among Medicare patients with atrial fibrillation. , 1998, Archives of internal medicine.
[14] D. Levy,et al. Predictors of Thromboembolism in Atrial Fibrillation , 1992, Annals of Internal Medicine.
[15] M Gent,et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. , 1991, Journal of the American College of Cardiology.
[16] L. Poller,et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. , 1993, The New England journal of medicine.
[17] Palle Petersen,et al. PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.
[18] Bernard Rosner,et al. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. , 1990, The New England journal of medicine.
[19] Z. J. Lipowski. Letter: Psychosomatic medicine. , 1974, Lancet.
[20] Predictors of Thromboembolism in Atrial Fibrillation: I. Clinical Features of Patients at Risk , 1992, Annals of Internal Medicine.
[21] D. Singer,et al. Recent national patterns of warfarin use in atrial fibrillation. , 1998, Circulation.